A Vaccine of L2 Epitope Repeats Fused with a Modified IgG1 Fc Induced Cross-Neutralizing Antibodies and Protective Immunity against Divergent Human Papillomavirus Types

Current human papillomavirus (HPV) major capsid protein L1 virus-like particles (VLPs)-based vaccines in clinic induce strong HPV type-specific neutralizing antibody responses. To develop pan-HPV vaccines, here, we show that the fusion protein E3R4 consisting of three repeats of HPV16 L2 aa 17–36 ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xue, Liu, Hongyang, Zhang, Ting, Liu, Yanchun, Xie, Xixiu, Wang, Zhirong, Xu, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011685/
https://www.ncbi.nlm.nih.gov/pubmed/24802101
http://dx.doi.org/10.1371/journal.pone.0095448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011685/
https://www.ncbi.nlm.nih.gov/pubmed/24802101
http://dx.doi.org/10.1371/journal.pone.0095448

Ejemplares similares